Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma www.oncnursingnews.com/ - 27 Apr 2024 Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma ... More
FDA pushes back decision date on pz-cel treatment for RDEB Epidermolysis Bullosa News - 26 Apr 2024 FDA pushes back decision date on pz-cel treatment for RDEB ... More
Imugene doses first patient in US trial of Azer-cel allogeneic CAR T therapy Small Caps - 10 Nov 2023 Imugene doses first patient in US trial of Azer-cel allogeneic CAR T therapy ... More
Dr Binod Dhakal Discusses Game-Changing Cilta-Cel Approval for RRMM AJMC.com Managed Markets Network - 24 Apr 2024 Dr Binod Dhakal Discusses Game-Changing Cilta-Cel Approval for RRMM ... More
ODAC Decisions Confirm Benefit of Ide-Cel and Cilta-Cel in Earlier Line R/R Myeloma Therapy OncLive - 25 Apr 2024 ODAC Decisions Confirm Benefit of Ide-Cel and Cilta-Cel in Earlier Line R/R Myeloma Therapy ... More
FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel FiercePharma - 23 Apr 2024 FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel ... More
Abeona Therapeutics Provides Regulatory Update on Pz-cel Yahoo Finance Australia - 22 Apr 2024 Abeona Therapeutics Provides Regulatory Update on Pz-cel ... More
Nextivity CEL-FI Roam R41 review: boosting mobile coverage Gadgetguy.com.au - 08 Feb 2024 Nextivity CEL-FI Roam R41 review: boosting mobile coverage ... More
CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment Contemporary Pediatrics - 23 Apr 2024 CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment ... More
Afami-cel provides a novel treatment option for rare sarcoma subtypes Nature.com - 18 Apr 2024 Afami-cel provides a novel treatment option for rare sarcoma subtypes ... More
Call of Duty's upcoming Cel-Shaded skin opens new crossover possibilities in Warzone and MW3 Sportskeeda - 25 Apr 2024 Call of Duty's upcoming Cel-Shaded skin opens new crossover possibilities in Warzone and MW3 ... More
Cilta-cel Demonstrates 99.4% ORR in Lenalidomide-Refractory Myeloma www.oncnursingnews.com/ - 25 Apr 2024 Cilta-cel Demonstrates 99.4% ORR in Lenalidomide-Refractory Myeloma ... More
The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD MD Magazine - 06 Mar 2024 The Prospect of Pz-cel in RDEB Treatment, with Peter Marinkovich, MD ... More
European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy OncLive - 22 Apr 2024 European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy ... More
How Cel-Fi booster technology conquers mobile dead zones Gadgetguy.com.au - 03 Apr 2024 How Cel-Fi booster technology conquers mobile dead zones ... More
Imugene raising $65 million to fund global growth, acquire Azer-cel Small Caps - 18 Aug 2023 Imugene raising $65 million to fund global growth, acquire Azer-cel ... More
Cilta-cel Produces MRD Negativity, Responses in Relapsed/Refractory Multiple Myeloma www.oncnursingnews.com/ - 26 Apr 2024 Cilta-cel Produces MRD Negativity, Responses in Relapsed/Refractory Multiple Myeloma ... More
Cilta-Cel Allows for Treatment-Free Period in Early R/R Multiple Myeloma OncLive - 22 Apr 2024 Cilta-Cel Allows for Treatment-Free Period in Early R/R Multiple Myeloma ... More
Imugene raises $18.2m to fund azer-cel worldwide licencing deal Small Caps - 25 Sep 2023 Imugene raises $18.2m to fund azer-cel worldwide licencing deal ... More